HERE WE GO! Super excited to have matched at @YaleIMed @YaleMedPSTP @YaleHemOnc fulfilling my dream of becoming a physician-scientist! I can’t wait to start! Thankful to @MarkDSiegel1 @DelaCruzYaleMed #AlfredLee for believing in me and to my colleagues/mentors for supporting me!
Talal El Zarif, MD
10.9K posts
- Taking a moment to appreciate all the amazing people behind this study out today @JCO_ASCO that has been in the works for 2+ years. Hoping that it can guide oncologists caring for people living w/ #HIV and #cancer. ascopubs.org/doi/abs/10.120…
- So excited to be joining this group of people! This map below reflects where members of the incoming class of @YaleIMed were born or raised. @Dr_AmerZeidan @MarkDSiegel1 @DelaCruzYaleMedProgram Director's Notes: Getting to Know You (Introducing our new interns). medicine.yale.edu/intmed/residen… @YaleIMed @YaleIM_Chiefs #Match2023 #ProgramDirectorsNotes 1/7
- 🚨Very excited to share that our work on the safety and efficacy of immune checkpoint inhibitors in patients living with #HIV has been accepted as an oral presentation @sitcancer!! This is part of the Cancer Therapy using Checkpoint inhibitors in PLWH-International (CATCH-IT)..
- 1/10. After our oral presentation at #GU23, we are excited to share our Lancet preprint on ICIs for penile cancer! Work co-led w/ @AminNassarMD & supervised by @sonpavde @apolo_andrea. A global study from @GTumors! @AndreaNecchi @SpiessPhilippe @DrChoueiri papers.ssrn.com/sol3/papers.cf…
- 🚨On behalf of my amazing co-authors, I'm super excited to share our findings on safety/efficacy of #ICI for #NSCLC among people living w/ #HIV as an oral presentation #SITC2022 (Thurs. @ 7pm). Effort co-led w/🌟@AminNassarMD @adib_elio & best mentors @thenasheffect @sonpavde!
- Myocarditis‐associated cardiogenic shock is uncommon but carries a high mortality with greater use of advanced support. Our work in @JAHA_AHA, presented at #ACC25, examines outcomes in this critically ill population. Grateful to @ElliottMillerMD and co-authors for their support!
- “Since 2011, the year I became PD, we’ve matched IMGs from India, Iran, Israel, Saudi Arabia, Turkey, Greece, Italy, Austria, Germany, Denmark, Russia, Colombia, Peru, Brazil, Mexico, and Canada. This year, we’re trying for more.” I do remember this tweet very well… (1/2)A Year of Open Doors (A New Year's Message to My @YAleim Residents) medicine.yale.edu/intmed/residen… @YaleIM_Chiefs
- Last day in my beautiful hometown Sidon, Lebanon ☀️ before heading back to Boston (expected snowstorm tomorrow) ❄️. Warm sun, 60F temperature, Mediterranean sea, and humble fishermen. Sometimes it’s just the simple things!
- Day made thanks to @ASCOTECAG @ASCO for providing a platform for young trainees at #ASCO24 as we presented our work from @YaleIMed @YaleCancer @StockhammerPaul @MJGrantMD! @FernandoDiazMD1 @jacobadashek
- 🚨Out now @CCR_AACR! We demonstrate accurate non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling! Led by @Cbmeador @Xintao_Qiu & guided by @jberchuck #MattFreedman @DanaFarber @MGHCancerCenter doi.org/10.1158/1078-0…
- Today we share in @JNCI_Now the final results of our experience on ICI use for penile cancer. Work presented at @ASCO #GU23. Thankful to co-first author @AminNassarMD, co-senior authors @sonpavde @apolo_andrea, colleagues, and patients from across the 🌎! academic.oup.com/jnci/advance-a…
















